Richard Pazdur

FDA

Biotech

AACR: Pazdur bemoans state of FDA, warns of political influence

Asked by Fierce if he'd consider returning to the FDA, Pazdur said he wouldn't serve again under the Trump administration "for obvious reasons."

Darren Incorvaia Apr 18, 2026 4:00am

FDA

CDER head Richard Pazdur retiring from FDA

Dec 2, 2025 12:55pm

Richard Pazdur

Fierce Pharma

FDA names oncology vet Pazdur as new CDER director

Nov 11, 2025 5:18pm

Richard Pazdur

FDA's Richard Pazdur explains confirmatory trial rejection, more

Apr 8, 2024 6:00am

Richard Pazdur

FDA looks to bypass cancer drugs' companion diagnostics: Pazdur

Nov 18, 2022 9:17am

Pazdur

Follow-up trials should be underway for accelerated nods: Pazdur

Nov 17, 2022 3:36pm